Please try another search
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Wei Zhang | 61 | 2019 | Independent Director |
Jing Lou | 60 | 2018 | Chairman of the Board |
Yongli Jin | 65 | 2019 | Independent Director |
Fanzhi Huang | 56 | 2021 | Independent Director |
Jing Wu | 28 | 2021 | Employee Representative Supervisor |
Dongmei Su | 53 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review